Discovery of the Selective Protein Kinase C-θ Kinase Inhibitor, CC-90005

被引：4

作者：

Papa, Patrick ^{[1
]}

Whitefield, Brandon ^{[1
]}

Mortensen, Deborah S. ^{[1
]}

Cashion, Dan ^{[1
]}

Huang, Dehua ^{[1
]}

Torres, Eduardo ^{[1
]}

Parnes, Jason ^{[1
]}

Sapienza, John ^{[1
]}

Hansen, Joshua ^{[1
]}

Correa, Matthew ^{[1
]}

Delgado, Mercedes ^{[1
]}

Harris, Roy ^{[1
]}

Hegde, Sayee ^{[1
]}

Norris, Stephen ^{[1
]}

Bahmanyar, Sogole ^{[1
]}

Plantevin-Krenitsky, Veronique ^{[1
]}

Liu, Zheng ^{[1
]}

Leftheris, Katerina ^{[1
]}

Kulkarni, Ashutosh ^{[1
]}

Bennett, Brydon ^{[1
]}

Hur, Eun Mi ^{[2
]}

Ringheim, Garth ^{[2
]}

Khambatta, Godrej ^{[1
]}

Chan, Henry ^{[1
]}

Muir, Jeffrey ^{[1
]}

Blease, Kate ^{[1
]}

Burnett, Kelven ^{[1
]}

LeBrun, Laurie ^{[1
]}

Morrison, Lisa ^{[1
]}

Celeridad, Maria ^{[1
]}

Khattri, Roli ^{[1
]}

Cathers, Brian E. ^{[1
]}

机构：

[1] Bristol Myers Squibb, San Diego, CA 92121 USA

[2] Bristol Myers Squibb, Summit, NJ 07901 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2021年 / 64卷 / 16期

关键词：

KAPPA-B ACTIVATION; PKC-THETA; OPTIMIZATION; AUTOIMMUNITY; AEB071; CELLS; MICE;

D O I：

10.1021/acs.jmedchem.1c00388

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The PKC-theta isoform of protein kinase C is selectively expressed in T lymphocytes and plays an important role in the T cell antigen receptor (TCR)-triggered activation of mature T cells, T cell proliferation, and the subsequent release of cytokines such as interleukin-2 (IL-2). Herein, we report the synthesis and structure-activity relationship (SAR) of a novel series of PKC-theta inhibitors. Through a combination of structure-guided design and exploratory SAR, suitable replacements for the basic C4 amine of the original lead (3) were identified. Property-guided design enabled the identification of appropriately substituted C2 groups to afford potent analogs with metabolic stability and permeability to support in vivo testing. With exquisite general kinase selectivity, cellular inhibition of T cell activation as assessed by IL-2 expression, a favorable safety profile, and demonstrated in vivo efficacy in models of acute and chronic T cell activation with oral dosing, CC-90005 (57) was selected for clinical development.

引用

页码：11886 / 11903

页数：18

共 50 条

[1] Discovery of the Selective Protein Kinase C-θ Kinase Inhibitor, CC-90005 (vol 64, pg 11886, 2021)
Papa, Patrick
Whitefield, Brandon
Mortensen, Deborah S.
Cashion, Dan
Huang, Dehua
Torres, Eduardo
Parnes, Jason
Sapienza, John
Hansen, Joshua
Correa, Matthew
Delgado, Mercedes
Harris, Roy
Hegde, Sayee
Norris, Stephen
Bahmanyar, Sogole
Plantevin-Krenitsky, Veronique
Liu, Zheng
Leftheris, Katerina
Kulkarni, Ashutosh
Bennett, Brydon
Hur, Eun Mi
Ringheim, Garth
Khambatta, Godrej
Chan, Henry
Muir, Jeffrey
Blease, Kate
Burnett, Kelven
Lebrun, Laurie
Morrison, Lisa
Celeridad, Maria
Khattri, Roli
Cathers, Brian E.
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (24) : 22344 - 22344
[2] INHIBITION OF PROTEIN KINASE C THETA BY THE SELECTIVE INHIBITOR CC-90005 INDUCES T CELL ANERGY
Hur, E. M.
Capone, L.
Kosek, J.
Schafer, P. H.
Ringheim, G. E.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 780 - 780
[3] Inhibition of angiogenesis by a novel, selective inhibitor of protein kinase C-β.
Derian, CK
Zhang, HC
Andrade-Gordon, P
Maryanoff, BE
Tuman, RW
Addo, MF
Croll, DR
Damiano, BP
Eckardt, AJ
Emanuel, S
Hecker, LR
Johnson, DL
McComsey, DF
Skrzat, S
Tominovich, R
White, KB
Ye, H
BLOOD, 2003, 102 (11) : 534A - 534A
[4] T-Cell Receptor Signaling Inhibition By CC-90005, a Selective Protein Kinase C Theta Antagonist, Reduces Antigen Mediated T-Cell Activation and Arthritis Pathology in the Mouse CIA Model
Ringheim, Garth
Kosek, Jolanta
Capone, Lori
Hur, Eun Mi
Schafer, Peter H.
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[5] Protein kinase C isoenzyme:: selective expression pattern of protein kinase C-θ during mouse development
Wilda, M
Ghaffari-Tabrizi, N
Reisert, I
Utermann, G
Baier, G
Hameister, H
MECHANISMS OF DEVELOPMENT, 2001, 103 (1-2) : 197 - 200
[6] Genetics and molecular biology -: protein kinase C-ζ as an AMP-activated protein kinase kinase kinase:: the protein kinase C-ζ-LKB1-AMP-activated protein kinase pathway
Li, Cai
CURRENT OPINION IN LIPIDOLOGY, 2008, 19 (05) : 541 - 542
[7] Recent discovery and development of selective protein kinase C inhibitors
Hu, H
DRUG DISCOVERY TODAY, 1996, 1 (10) : 438 - 447
[8] Discovery of a potent and selective Aurora kinase inhibitor
Oslob, Johan D.
Romanowski, Michael J.
Allen, Darin A.
Baskaran, Subramanian
Bui, Minna
Elling, Robert A.
Flanagan, William M.
Fung, Amy D.
Hanan, Emily J.
Harris, Shannon
Heumann, Stacey A.
Hoch, Ute
Jacobs, Jeffrey W.
Lam, Joni
Lawrence, Chris E.
McDowell, Robert S.
Nannini, Michelle A.
Shen, Wang
Silverman, Jeffrey A.
Sopko, Michelle M.
Tangonan, Bradley T.
Teague, Juli
Yoburn, Josh C.
Yu, Chul H.
Zhong, Min
Zimmerman, Kristin M.
O'Brien, Tom
Lew, Willard
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (17) : 4880 - 4884
[9] A protein kinase C-β-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats
Nakamura, J
Kato, K
Hamada, Y
Nakayama, M
Chaya, S
Nakashima, E
Naruse, K
Kasuya, Y
Mizubayashi, R
Miwa, K
Yasuda, Y
Kamiya, H
Ienaga, K
Sakakibara, F
Koh, N
Hotta, N
DIABETES, 1999, 48 (10) : 2090 - 2095
[10] Effect of a protein kinase C-β specific inhibitor on diabetic neuropathy in rats
Nakamura, J
Koh, N
Hamada, Y
Naruse, K
Chaya, S
Kato, K
Ienaga, K
Hotta, N
DIABETES, 1998, 47 : A70 - A70

← 1 2 3 4 5 →